http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100959557-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-09 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate | 2008-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2010-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2010-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100959557-B1 |
titleOfInvention | Pharmaceutical composition for the prevention and treatment of diabetes or PIA-gamma-mediated diseases comprising nutmeg adenocarcinoma extract compound |
abstract | The present invention relates to a pharmaceutical composition for preventing and treating diabetes comprising the nutmeg alfalfa extract compound as an active ingredient, and more particularly, 2- (4-allyl-2,6-dime, which is a compound extracted from the apiary skin of nutmeg It relates to a pharmaceutical composition for preventing and treating diabetes comprising oxyphenoxy) -1- (4-hydroxy-3-methoxyphenyl) -propane, austrobi lignan 7 or lycarin E as an active ingredient. 2- (4-allyl-2,6-dimethoxyphenoxy) -1- (4-hydroxy-3-methoxyphenyl) -propane, austrobylignan 7 and lycarin E of the present invention are nutmeg adenocarcinoma (Aril of nutmeg) is a compound isolated from the extract, and the nutmeg of the nutmeg extract acts as a ligand of PPARγ to activate PPARγ for the purpose of preventing and treating diseases such as diabetes and diabetic complications mediated by PPARγ Can be used. See also 2- (4-allyl-2,6-dimethoxyphenoxy) -1- (4-hydroxy-3-methoxyphenyl) -propane, austrobylignan 7, lycarin E and nutmeg ail of nutmeg) extract can also be used as a preventive and therapeutic agent for diabetes by reducing blood sugar.n n n n 2- (4-allyl-2,6-dimethoxyphenoxy) -1- (4-hydroxy-3-methoxyphenyl) -propane, austrobylignan 7, lycarin E, nutmeg albino, diabetes |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102242195-B1 |
priorityDate | 2007-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 256.